Fernanda Souza Macchi

Fernanda Souza Macchi

Auto-generated profile, based on publicly available information

Fernanda Souza Macchi

Instituto Nacional de Ciência e Tecnologia em Tuberculose, Centro de Pesquisas em Biologia Molecular e Funcional, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2018 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
FMFernanda Souza Macchi
Fernanda Souza Macchi
KPKenia Pissinate
Kenia Pissinate
AVAnne Drumond Villela
Anne Drumond Villela
BABruno Abbadi
Bruno Abbadi
VRValnês Rodrigues-Junior
Valnês Rodrigues-Junior
PMPablo Machado
Pablo Machado

16 August 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
TMThaís C. Muradás
Thaís C. Muradás
BABruno Abbadi
Bruno Abbadi
AVAnne D. Villela
Anne D. Villela
FMFernanda S. Macchi
Fernanda S. Macchi
PBPedro F. Bergo
Pedro F. Bergo
VRValnês da Silva Rodrigues-Junior
Valnês da Silva Rodrigues-Junior
New effective compounds for tuberculosis treatment are needed. This study evaluated the effects of a series of quinoxaline-derived chalcones against laboratorial strains and clinical isolates of M. tuberculosis. Six molecules, namely N5, N9, N10, N15, N16, and N23 inhibited the growth of the M. tuberculosis H37Rv laboratorial strain. The three compounds (N9, N15 and N23) with the lowest MIC values were further tested against clinical isolates and laboratory strains with mutations in katG or inhA genes. From these data, N9 was selected as the lead compound for further investigation. Importantly, this chalcone displayed a synergistic effect when combined with moxifloxacin. Noteworthy, the anti-tubercular effects of N9 did not rely on inhibition of mycolic acids synthesis, circumventing important mechanisms of resistance. Interactions with cytochrome P450 isoforms and toxic effects were assessed in silico and in vitro. The chalcone N9 was not predicted to elicit any mutagenic, genotoxic, irritant, or reproductive effects, according to in silico analysis. Additionally, N9 did not cause mutagenicity or genotoxicity, as revealed by Salmonella/microsome and alkaline comet assays, respectively. Moreover, N9 did not inhibit the cytochrome P450 isoforms CYP3A4/5, CYP2C9, and CYP2C19. N9 can be considered a potential lead molecule for development of a new anti-tubercular therapeutic agent.

1 February 2018 in Journal of Inorganic Biochemistry
Verified
Journal Article
Closed access
JLJulie Laborde
Julie Laborde
CDCéline Deraeve
Céline Deraeve
FVFrancisca Gilmara de Mesquita Vieira
Francisca Gilmara de Mesquita Vieira
ASAlix Sournia-Saquet
Alix Sournia-Saquet
LRLionel Rechignat
Lionel Rechignat
VGVania Bernardes Génisson
Vania Bernardes Génisson

7 January 2019 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
NSNathalia D. de Moura Sperotto
Nathalia D. de Moura Sperotto
CRCandida Deves Roth
Candida Deves Roth
VRValnês S. Rodrigues-Junior
Valnês S. Rodrigues-Junior
CNChristiano Ev Neves
Christiano Ev Neves
FPFávero Reisdorfer Paula
Fávero Reisdorfer Paula
PMPablo Machado
Pablo Machado

1 January 2016 in Brazilian Archives of Biology and Technology
Verified
Journal Article
Open access
MGMárcia Gonçalves
Márcia Gonçalves
ÁCÁngelica Regina Cappellari
Ángelica Regina Cappellari
AJAndré Avelino dos Santos Junior
André Avelino dos Santos Junior
FMFernanda Olicheski de Marchi
Fernanda Olicheski de Marchi
FMFernanda Souza Macchi
Fernanda Souza Macchi
BBBrasil Instituto de Pesquisa Biomedicina
Brasil Instituto de Pesquisa Biomedicina
The esophagus and mouth tumors are very frequent malignancies worldwide. Lipopolysaccharides (LPS) are capable of regulating gene expression of pro-inflammatory cytokines by binding to toll-like receptor 4 (TLR4). Recent studies show that LPS can increase the migration ability of human esophageal cancer cell line HKESC-2 by increasing its adhesion properties. However, the effect of LPS has not been tested on viability of human esophageal and oral cancer cells. This study aimed to determine the action of LPS on the cell proliferation and viability in OE19 (adenocarcinoma) and OE21 (squamous carcinoma) cell lines, representative of human esophageal cancer, and HN30 cell line, representative of human oral carcinoma. LPS was used as treatment to OE19 and OE21 cells, and PgLPS (Porphyromonasgingivalis lipopolysaccharide) to HN30 cells. Viability was assessed by MTT assay and proliferation by cell counting. TLR4 expression was evaluated by real-time PCR. LPS at higher concentrations decreased significantly cell viability in both cell lines, adenocarcinoma (OE19) and squamous esophageal carcinoma (OE21) at different times of treatment. In addition, both cell lines, OE19 and OE21, expressed TLR4 receptor. Taken together, our data demonstrated that LPS at high concentrations might contribute to tumor death, in agreement with previously data

7 June 2017 in Synthetic Communications
Verified
Journal Article
Closed access
ABAna Flávia Borsoi
Ana Flávia Borsoi
MCMateus Emanuel Coldeira
Mateus Emanuel Coldeira
KPKenia Pissinate
Kenia Pissinate
FMFernanda Souza Macchi
Fernanda Souza Macchi
LBLuiz Basso
Luiz Basso
PMPablo Machado
Pablo Machado
A ultrasound-assisted oxidative cyclization of semicarbazones using N-bromosuccinimide in the presence of sodium acetate was established providing efficient and rapid access to a variety of 2-amino-1,3,4-oxadiazoles. Moreover, the new synthetic protocol provides a simple procedure utilizing a safer oxidizing system that affords the target products in high regioselectivity, satisfactory yields, and elevated purities. GRAPHICAL ABSTRACT